These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9423278)

  • 1. A neuropsychological study of prefrontal lobe function in the positive and negative subtypes of schizophrenia.
    Mattson DT; Berk M; Lucas MD
    J Genet Psychol; 1997 Dec; 158(4):487-94. PubMed ID: 9423278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological frontal impairments and negative symptoms in schizophrenia.
    Martino DJ; Bucay D; Butman JT; Allegri RF
    Psychiatry Res; 2007 Aug; 152(2-3):121-8. PubMed ID: 17507100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community dysfunction in schizophrenia: rate-limiting factors.
    Bozikas VP; Kosmidis MH; Kafantari A; Gamvrula K; Vasiliadou E; Petrikis P; Fokas K; Karavatos A
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):463-70. PubMed ID: 16442195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment of executive function as a core symptom of schizophrenia.
    Wobrock T; Ecker UK; Scherk H; Schneider-Axmann T; Falkai P; Gruber O
    World J Biol Psychiatry; 2009; 10(4 Pt 2):442-51. PubMed ID: 18609418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological performance in first-episode adolescents with schizophrenia: a comparison with first-episode adults and adolescent control subjects.
    White T; Ho BC; Ward J; O'Leary D; Andreasen NC
    Biol Psychiatry; 2006 Sep; 60(5):463-71. PubMed ID: 16566898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Context processing and negative symptoms in schizophrenia.
    Thoma P; Zoppelt D; Wiebel B; Daum I
    J Clin Exp Neuropsychol; 2007 May; 29(4):428-35. PubMed ID: 17497566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
    Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A
    J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
    Penadés R; Gastó C; Boget T; Catalán R; Salamero M
    Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
    Huguelet P; Nicastro R; Zanello A
    Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between psychopathology and cognitive functioning in schizophrenia.
    Bozikas VP; Kosmidis MH; Kioperlidou K; Karavatos A
    Compr Psychiatry; 2004; 45(5):392-400. PubMed ID: 15332203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia.
    Heslegrave RJ; Awad AG; Voruganti LN
    J Psychiatry Neurosci; 1997 Jul; 22(4):235-43. PubMed ID: 9262045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intentionality as a link between the neuropsychology and the symptoms of schizophrenia.
    Kaiser S; Weisbrod M
    Psychopathology; 2007; 40(4):221-8. PubMed ID: 17396048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verbal fluency and psychiatric symptoms in geriatric schizophrenia.
    Howanitz E; Cicalese C; Harvey PD
    Schizophr Res; 2000 May; 42(3):167-9. PubMed ID: 10785575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairments of executive/attentional functions in schizophrenia with primary and secondary negative symptoms.
    Brazo P; Delamillieure P; Morello R; Halbecq I; Marié RM; Dollfus S
    Psychiatry Res; 2005 Jan; 133(1):45-55. PubMed ID: 15698676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological characteristics associated with olfactory hallucinations in schizophrenia.
    Arguedas D; Langdon R; Stevenson R
    J Int Neuropsychol Soc; 2012 Sep; 18(5):799-808. PubMed ID: 22613466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia.
    Harvey PD; Serper MR; White L; Parrella MJ; McGurk SR; Moriarty PJ; Bowie C; Vadhan N; Friedman J; Davis KL
    Compr Psychiatry; 2001; 42(4):306-13. PubMed ID: 11458305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theory of mind in schizophrenia: the role of clinical symptomatology and neurocognition in understanding other people's thoughts and intentions.
    Abdel-Hamid M; Lehmkämper C; Sonntag C; Juckel G; Daum I; Brüne M
    Psychiatry Res; 2009 Jan; 165(1-2):19-26. PubMed ID: 19073346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.